Alzinova testimonial: Alzheimer’s peptide vaccine with PolyPeptide

September is International Alzheimer’s Month, a reminder of the urgent need to advance research and treatment options for patients and families affected worldwide.

It is an honor to support companies like Alzinova in their mission to develop innovative medicines. By helping accelerate manufacturing, we aim to ensure these therapies reach the bedside as quickly as possible and bring hope to those in need.

At PolyPeptide, we know solubility challenges often stand in the way of progress. We strive to be the most innovative peptide CDMO — finding solutions where others stop, so breakthroughs in Alzheimer’s research can become reality for patients. Progress in this field depends on collaboration, commitment, and continuous innovation.

Watch the testimonial with Tord Labuda, CEO, MSc PhD. Alzinova AB to learn more about the collaboration.

More information was shared in the press release from April 24, 2025.